Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115261) titled 'A Real-World Multicenter Prospective Clinical Study of TAS-102 Combination Regimen in Third-Line and Beyond Treatment for HER-2 Negative Advanced Gastric Cancer Patients' on Dec. 24, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Bengbu Medical University
Condition:
Gastric Cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-25
Target Sample Size: Research group:95;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=302347
Published by HT Digital Conte...